Author:
Roy Priyabrata,Bodhak Chandan,Pramanik Animesh
Funder
Dr D. S. Kothari Postdoctoral Fellowship, UGC
Publisher
Springer Science and Business Media LLC
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis
Reference25 articles.
1. Özkay Y, Tunali Y, Karaca H, Isikdag I (2010) Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety. Eur J Med Chem 45:3293–3298. doi:
10.1016/j.ejmech.2010.04.012
2. Horton DA, Bourne GT, Smythe ML (2003) The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 103:893–930. doi:
10.1021/cr020033s
3. Coban G, Zencir S, Zupkó I, Réthy B, Gunes HS, Topcu Z (2009) Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays. Eur J Med Chem 44:2280–2285. doi:
10.1016/j.ejmech.2008.06.018
4. Deady LW, Rodemann WT, Finlay GJ, Baguley BC, Denny WA (2000) Synthesis and cytotoxic activity of carboxamide derivatives of benzimidazo[2,1-
$$a$$
a
]isoquinoline and pyrido[3
$$\prime $$
′
,2
$$\prime $$
′
:4,5]imidazo[2,1-
$$a$$
a
]isoquinoline. Anti-Cancer Drug Des 15:339–346
5. Hordan AD, Vaidya AH, Rosenthal DI, Dubinsky B, Kordik CP, Sanfilippo PJ, Wu WN, Reitz AB (2002) Potential anxiolytic agents. Part 4: novel orally-active N
$$^{5}$$
5
-substituted pyrido[1,2-
$$a$$
a
] benzimidazoles with high GABA-A receptor affinity. Bioorg Med Chem Lett 12:2381–2386. doi:
10.1016/S0960-894X(02)00463-8